Stability of vitamin K antagonist anticoagulation after COVID-19 diagnosis.

Eleonora Camilleri Nienke van ReinFelix J M van der MeerMelchior C NiermanWillem M Lijfering Suzanne C Cannegieternull null

Published in: Research and practice in thrombosis and haemostasis (2021)

COVID-19 is associated with a strong decrease in TTR and in therapeutic stability in patients taking VKAs. Additional monitoring in these patients is advised to maximize therapeutic stability.

Keyphrases

end stage renal disease
coronavirus disease
chronic kidney disease
newly diagnosed
ejection fraction
sars cov
prognostic factors
peritoneal dialysis
atrial fibrillation